NO20041196L - Kontrollerte frigjoringsformuleringer for claritromycin eller tinidazol. - Google Patents

Kontrollerte frigjoringsformuleringer for claritromycin eller tinidazol.

Info

Publication number
NO20041196L
NO20041196L NO20041196A NO20041196A NO20041196L NO 20041196 L NO20041196 L NO 20041196L NO 20041196 A NO20041196 A NO 20041196A NO 20041196 A NO20041196 A NO 20041196A NO 20041196 L NO20041196 L NO 20041196L
Authority
NO
Norway
Prior art keywords
tinidazole
clarithromycin
controlled release
release formulations
formulations
Prior art date
Application number
NO20041196A
Other languages
English (en)
Norwegian (no)
Inventor
Ashok Rampal
Manoj Kumar
Rajeev S Raghuvanshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2001/001564 external-priority patent/WO2002017885A2/en
Priority claimed from PCT/IB2002/000175 external-priority patent/WO2003017981A1/en
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of NO20041196L publication Critical patent/NO20041196L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20041196A 2001-08-29 2004-03-23 Kontrollerte frigjoringsformuleringer for claritromycin eller tinidazol. NO20041196L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2001/001564 WO2002017885A2 (en) 2000-08-29 2001-08-29 Controlled release formulation of erythromycin or a derivative thereof
PCT/IB2002/000175 WO2003017981A1 (en) 2001-08-29 2002-01-22 Controlled release formulation of clarithromycin or tinidazol

Publications (1)

Publication Number Publication Date
NO20041196L true NO20041196L (no) 2004-03-23

Family

ID=32259846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041196A NO20041196L (no) 2001-08-29 2004-03-23 Kontrollerte frigjoringsformuleringer for claritromycin eller tinidazol.

Country Status (10)

Country Link
US (1) US20050053657A1 (de)
EP (1) EP1423097A1 (de)
CN (1) CN1575164A (de)
BR (1) BR0212259A (de)
CA (1) CA2458776A1 (de)
EA (1) EA200400343A1 (de)
HU (1) HUP0500791A2 (de)
NO (1) NO20041196L (de)
PL (1) PL368306A1 (de)
ZA (1) ZA200402007B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
EP2283824B1 (de) * 2009-07-30 2017-04-19 Special Products Line S.p.A. Zusammensetzungen und Formulierungen, die auf quellbaren Matrizen basieren, zur verzögerten Freisetzung von schlecht löslichen Arzneimitteln, wie zum Beispiel Clarithromycin
EP2671571A1 (de) * 2012-06-05 2013-12-11 Sanovel Ilac Sanayi ve Ticaret A.S. Formulierungen von Clarithromycin mit gesteuerter Freisetzung
CN104042585B (zh) * 2014-05-21 2016-08-24 丽珠医药集团股份有限公司 一种替硝唑的口服制剂
CN105310990B (zh) * 2014-12-04 2018-01-19 蚌埠丰原涂山制药有限公司 一种防止粘冲和裂片的对乙酰氨酚片及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4076804A (en) * 1975-07-18 1978-02-28 Abbott Laboratories Erythromycin therapy
GB1577196A (en) * 1977-06-03 1980-10-22 Ile De France Compositions containing erythromycin and metoclopramide
US4119723A (en) * 1977-07-08 1978-10-10 John R. A. Simoons Treatment of rheumatoid arthritis and related diseases
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5009897A (en) * 1988-06-24 1991-04-23 Abbott Laboratories Pharmaceutical granules and tablets made therefrom
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
US5705190A (en) * 1995-12-19 1998-01-06 Abbott Laboratories Controlled release formulation for poorly soluble basic drugs
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
US5869098A (en) * 1997-08-20 1999-02-09 Fuisz Technologies Ltd. Fast-dissolving comestible units formed under high-speed/high-pressure conditions
IN186245B (de) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
WO2003024427A1 (en) * 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form

Also Published As

Publication number Publication date
EP1423097A1 (de) 2004-06-02
CA2458776A1 (en) 2003-03-06
HUP0500791A2 (en) 2006-09-28
US20050053657A1 (en) 2005-03-10
BR0212259A (pt) 2004-10-19
PL368306A1 (en) 2005-03-21
EA200400343A1 (ru) 2004-08-26
ZA200402007B (en) 2004-09-15
CN1575164A (zh) 2005-02-02

Similar Documents

Publication Publication Date Title
DE60202924D1 (de) Flugzeugsteuerungssystem
NO20012636L (no) Kontrollert frigivelsesformulering som omfatter GNRH-II
DE60225265D1 (de) Unterhaltungssystem
DE60128730D1 (de) Elektromagnetisch-gekoppelte verbindungssystemarchitektur
NL1019181A1 (nl) Gestabiliseerd metalloceen-polypropeen.
NO20040040L (no) Forbedret lotterisystem
DE50203420D1 (de) Aktorsystem
ES1049932Y (es) Organo de mando multidireccional.
FI20010429A (fi) Punnitusjärjestelmä
NO20041196L (no) Kontrollerte frigjoringsformuleringer for claritromycin eller tinidazol.
DE60219994D1 (de) Röntgensystem
DE60214042D1 (de) Nass-trocken-reinigungssystem
NO20040966L (no) Orale vaksiner.
DE60119095D1 (de) Bilderzeugendes System
FI20021780A0 (fi) Menetelmät ja laitteet järjestelmän käyttämiseksi
ITTO20010691A0 (it) Sistema di fitodepurazione artificiale.
PT1408035E (pt) Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros
NL1011196A1 (nl) Plafondsysteem.
FI20000286A (fi) Jonotusjärjestelmä
NO20015348D0 (no) Redningssystem
DE10082489D2 (de) Ausrücksystem
SE0100908D0 (sv) Pulsaren - avloppssystem
ES1049731Y (es) Dispositivo para la administracion de farmacos.
IT249044Y1 (it) Dispositivo di salvataggio perfezionato per interventi di soccorso con elicotteri.
ES1048692Y (es) Sistema de cremallera para panelaje expositivo.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application